Literature DB >> 16787839

Oxidative neuropathology and putative chemical entities for Alzheimer's disease: neuroprotective effects of salen-manganese catalytic anti-oxidants.

H T Rupniak1, K A Joy, C Atkin, G Brown, J C Barnes, S R Doctrow, B Malfroy, T Wong, I K Anderson, C R Molloy, G I Mills, P Soden.   

Abstract

Considerable evidence exists that the brains of individuals with Alzheimer's disease are subject to elevated levels of oxidative stress, particularly in regions exhibiting pathological damage. A major contributor to this oxidative stress appears to be the inflammatory process. Activation of rodent microglial cells by LPS or beta-amyloid peptide results in a marked up-regulation of inducible nitric oxide synthase (iNOS) and corresponding nitric oxide (NO) production. Elevated levels of iNOS are also observed in the brains of Alzheimer patients. The reaction of NO with superoxide leads to the generation of the highly reactive and damaging peroxynitrite free radical species. Peroxynitrite appears to play a key role in the generation of an oxidative stress in the Alzheimer brain as evidenced by widespread nitrotyrosine immunoreactivity. We have employed SIN-1 as a peroxynitrite generating system in cell cultures in order to characterize the effects of this free radical on neurons. SIN-1 treatment of primary rat hippocampal neurons in culture results in neurotoxicity by a necrosis mechanism according to electron microscopic criteria. One approach to limiting peroxynitrite mediated damage is to limit superoxide production. An approach we have evaluated is treatment with salen manganese compounds, a class of catalytic antioxidant compounds which behave as superoxide dismutase (SOD)/catalase mimetics to detoxify superoxide. A number of such salen manganese compounds, including EUK-8 and EUK-134, can markedly protect primary rat cortical neurons from hydrogen peroxide mediated oxidative stress. Such salen manganese compounds can similarly afford marked neuroprotection to an oxidative stress imposed by SIN-1, potentially attributable at least in part to their inherent SOD activity. The salen manganese SOD/catalase mimetics represent a promising class of catalytic antioxidant for attenuating oxidative stress.

Entities:  

Year:  2000        PMID: 16787839     DOI: 10.1007/bf03033792

Source DB:  PubMed          Journal:  Neurotox Res        ISSN: 1029-8428            Impact factor:   3.911


  41 in total

1.  Mechanism of superoxide generation by neuronal nitric-oxide synthase.

Authors:  S Pou; L Keaton; W Surichamorn; G M Rosen
Journal:  J Biol Chem       Date:  1999-04-02       Impact factor: 5.157

2.  Amyloid beta-peptide stimulates nitric oxide production in astrocytes through an NFkappaB-dependent mechanism.

Authors:  K T Akama; C Albanese; R G Pestell; L J Van Eldik
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-12       Impact factor: 11.205

3.  EUK-134, a synthetic superoxide dismutase and catalase mimetic, prevents oxidative stress and attenuates kainate-induced neuropathology.

Authors:  Y Rong; S R Doctrow; G Tocco; M Baudry
Journal:  Proc Natl Acad Sci U S A       Date:  1999-08-17       Impact factor: 11.205

4.  Catalytic scavenging of peroxynitrite by isomeric Mn(III) N-methylpyridylporphyrins in the presence of reductants.

Authors:  G Ferrer-Sueta; I Batinić-Haberle; I Spasojević; I Fridovich; R Radi
Journal:  Chem Res Toxicol       Date:  1999-05       Impact factor: 3.739

5.  Synthetic combined superoxide dismutase/catalase mimetics are protective as a delayed treatment in a rat stroke model: a key role for reactive oxygen species in ischemic brain injury.

Authors:  K Baker; C B Marcus; K Huffman; H Kruk; B Malfroy; S R Doctrow
Journal:  J Pharmacol Exp Ther       Date:  1998-01       Impact factor: 4.030

Review 6.  Role of nitric oxide in neurodegenerative diseases.

Authors:  J B Schulz; R T Matthews; M F Beal
Journal:  Curr Opin Neurol       Date:  1995-12       Impact factor: 5.710

7.  Effect of peroxynitrite on the mitochondrial respiratory chain: differential susceptibility of neurones and astrocytes in primary culture.

Authors:  J P Bolaños; S J Heales; J M Land; J B Clark
Journal:  J Neurochem       Date:  1995-05       Impact factor: 5.372

8.  Staurosporine-induced neuronal apoptosis.

Authors:  J Y Koh; M B Wie; B J Gwag; S L Sensi; L M Canzoniero; J Demaro; C Csernansky; D W Choi
Journal:  Exp Neurol       Date:  1995-10       Impact factor: 5.330

9.  beta-Amyloid toxicity in organotypic hippocampal cultures: protection by EUK-8, a synthetic catalytic free radical scavenger.

Authors:  A J Bruce; B Malfroy; M Baudry
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-19       Impact factor: 11.205

10.  Inducible nitric oxide synthase in tangle-bearing neurons of patients with Alzheimer's disease.

Authors:  Y Vodovotz; M S Lucia; K C Flanders; L Chesler; Q W Xie; T W Smith; J Weidner; R Mumford; R Webber; C Nathan; A B Roberts; C F Lippa; M B Sporn
Journal:  J Exp Med       Date:  1996-10-01       Impact factor: 14.307

View more
  5 in total

1.  Neuroprotective and neurorestorative strategies for neuronal injury.

Authors:  M F Beal; T Palomo; R M Kostrzewa; T Archer
Journal:  Neurotox Res       Date:  2000       Impact factor: 3.911

Review 2.  Impaired adaptive cellular responses to oxidative stress and the pathogenesis of Alzheimer's disease.

Authors:  Sarah J Texel; Mark P Mattson
Journal:  Antioxid Redox Signal       Date:  2011-02-17       Impact factor: 8.401

Review 3.  Oxidative stress and transcriptional regulation in Alzheimer disease.

Authors:  Qingli Shi; Gary E Gibson
Journal:  Alzheimer Dis Assoc Disord       Date:  2007 Oct-Dec       Impact factor: 2.703

Review 4.  Catalytic antioxidants and neurodegeneration.

Authors:  Tamara R Golden; Manisha Patel
Journal:  Antioxid Redox Signal       Date:  2009-03       Impact factor: 8.401

5.  Mitoprotective antioxidant EUK-134 stimulates fatty acid oxidation and prevents hypertrophy in H9C2 cells.

Authors:  Sreeja Purushothaman; R Renuka Nair
Journal:  Mol Cell Biochem       Date:  2016-08-11       Impact factor: 3.396

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.